These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34225864)

  • 1. Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases.
    Fang G; Yang X; Wang Q; Zhang A; Tang B
    Mater Sci Eng C Mater Biol Appl; 2021 Aug; 127():112212. PubMed ID: 34225864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogels in ophthalmic applications.
    Kirchhof S; Goepferich AM; Brandl FP
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):227-38. PubMed ID: 26032290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
    Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
    Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(2-hydroxyethyl methacrylate)/β-cyclodextrin-hyaluronan contact lens with tear protein adsorption resistance and sustained drug delivery for ophthalmic diseases.
    Li R; Guan X; Lin X; Guan P; Zhang X; Rao Z; Du L; Zhao J; Rong J; Zhao J
    Acta Biomater; 2020 Jul; 110():105-118. PubMed ID: 32339710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A biomimetic peptide-drug supramolecular hydrogel as eyedrops enables controlled release of ophthalmic drugs.
    Pan M; Ren Z; Ma X; Chen L; Lv G; Liu X; Li S; Li X; Wang J
    Acta Biomater; 2023 Sep; 167():195-204. PubMed ID: 37392932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic gels: Past, present and future.
    Al-Kinani AA; Zidan G; Elsaid N; Seyfoddin A; Alani AWG; Alany RG
    Adv Drug Deliv Rev; 2018 Feb; 126():113-126. PubMed ID: 29288733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Hydrogels Based Drug Delivery Systems for Ophthalmic Delivery.
    Gorantla S; Waghule T; Rapalli VK; Singh PP; Dubey SK; Saha RN; Singhvi G
    Recent Pat Drug Deliv Formul; 2019; 13(4):291-300. PubMed ID: 31912771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermosensitive PEG-PCL-PEG (PECE) hydrogel as an in situ gelling system for ocular drug delivery of diclofenac sodium.
    Luo Z; Jin L; Xu L; Zhang ZL; Yu J; Shi S; Li X; Chen H
    Drug Deliv; 2016; 23(1):63-8. PubMed ID: 24758189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic applications of contact lens-based drug delivery systems in ophthalmic diseases.
    Zhao L; Song J; Du Y; Ren C; Guo B; Bi H
    Drug Deliv; 2023 Dec; 30(1):2219419. PubMed ID: 37264930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review.
    Xinming L; Yingde C; Lloyd AW; Mikhalovsky SV; Sandeman SR; Howel CA; Liewen L
    Cont Lens Anterior Eye; 2008 Apr; 31(2):57-64. PubMed ID: 17962066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
    Jung HJ; Chauhan A
    Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review on revolutionizing ophthalmic therapy: Unveiling the potential of chitosan, hyaluronic acid, cellulose, cyclodextrin, and poloxamer in eye disease treatments.
    Wang TJ; Rethi L; Ku MY; Nguyen HT; Chuang AE
    Int J Biol Macromol; 2024 Jul; 273(Pt 2):132700. PubMed ID: 38879998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing ophthalmic delivery of a poorly water soluble drug from an aqueous in situ gelling system.
    Senjoti FG; Timmins P; Conway BR; Smith AM
    Eur J Pharm Biopharm; 2020 Sep; 154():1-7. PubMed ID: 32599271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epalrestat-loaded silicone hydrogels as contact lenses to address diabetic-eye complications.
    Alvarez-Rivera F; Concheiro A; Alvarez-Lorenzo C
    Eur J Pharm Biopharm; 2018 Jan; 122():126-136. PubMed ID: 29079419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication of a Micellar Supramolecular Hydrogel for Ocular Drug Delivery.
    Zhang Z; He Z; Liang R; Ma Y; Huang W; Jiang R; Shi S; Chen H; Li X
    Biomacromolecules; 2016 Mar; 17(3):798-807. PubMed ID: 26830342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogel-based ocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations.
    Cooper RC; Yang H
    J Control Release; 2019 Jul; 306():29-39. PubMed ID: 31128143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supramolecular nanofibers of dexamethasone derivatives to form hydrogel for topical ocular drug delivery.
    Zhang Z; Yu J; Zhou Y; Zhang R; Song Q; Lei L; Li X
    Colloids Surf B Biointerfaces; 2018 Apr; 164():436-443. PubMed ID: 29438842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.